Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:05 AM
Ignite Modification Date:
2025-12-25 @ 4:05 AM
NCT ID:
NCT04471402
Eligibility Criteria:
Inclusion Criteria:
* Children who would receive 3mcg/kg intranasal Precedex as a first line sedative agent for radiological procedures or for pre-anaesthesia sedation
* Written informed consent from parent or legal guardian
Exclusion Criteria:
* Known allergy or hypersensitivity to Precedex
* Pre-existing developmental delay
* Neurological impairment
* Autism
* Fever (temperature \>/= 38.5c)
* Major organ dysfunction
* Cardiac arrhythmia
* Cardiac failure
* Subjects who would require a dose exceeding 100mcg if 3mcg/kg dose is achieved
* Subjects who have failed intranasal administration of Dexmedetomidine
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
6 Months
Maximum Age:
12 Years
Study:
NCT04471402
Study Brief:
Protocol Section:
NCT04471402